BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. 2004

Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Faculty of Fragrance and Cosmetics, Kaohsiung Medical University, Kaohsiung, Taiwan.

In an effort to develop potent antiplatelet agents with anti-inflammatory action, a novel series of anti-inflammatory chalcones was screened to evaluate their antiplatelet effects. Structure-activity relationships and mode of action were investigated and characterized. The antiplatelet effects of the chalcones on washed rabbit platelets and human platelet-rich plasma were evaluated. Arachidonic acid-induced platelet aggregation was potently inhibited by almost all the chalcone derivatives. Collagen-induced platelet aggregation was potently inhibited by all the chalcone derivatives at 300 microM, except for compound 4 at 100 microM. Compounds 6, 7 and 9 significantly inhibited the aggregation of washed rabbit platelets induced by platelet-activating factor at 300 microM. Of the compounds tested in human platelet-rich plasma, compounds 2, 8 and 9 showed significant inhibition of secondary aggregation induced by adrenaline. It is concluded that the antiplatelet effect of 2, 8 and 9 is mainly owing to an inhibitory effect on thromboxane formation. The inhibitory effect of 6, 7 and 9 on platelet aggregation induced by platelet-activating factor could be owing to a calcium antagonizing effect or inhibition of intracellular calcium mobilization.

UI MeSH Term Description Entries
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Structure-activity relationship studies on chalcone derivatives. the potent inhibition of chemical mediators release.
January 2003, Bioorganic & medicinal chemistry,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors.
January 2019, Medicinal chemistry (Shariqah (United Arab Emirates)),
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Chalcone-based imidazo[2,1-b]thiazole derivatives: synthesis, crystal structure, potent anticancer activity, and computational studies.
November 2023, Journal of biomolecular structure & dynamics,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Quantitative structure-activity study of inhibition of blood platelet aggregation by aspirin derivatives [proceedings].
December 1977, The Journal of pharmacy and pharmacology,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
June 2019, Bioorganic & medicinal chemistry letters,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents.
August 2018, The Journal of antibiotics,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection.
March 2020, Journal of medicinal chemistry,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Cerebrovasodilatation activity and platelet and aggregation inhibition of allenyl derivatives.
February 1991, Die Pharmazie,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
March 1986, Il Farmaco; edizione scientifica,
Horng-Huey Ko, and Hsin-Kaw Hsieh, and Cheng-Tsung Liu, and Hsien-Chen Lin, and Che-Ming Teng, and Chun-Nan Lin
2-phenylethanol and some of its amphiphilic derivatives as inhibitors of platelet aggregation. Structure-activity relationship.
November 1975, Arzneimittel-Forschung,
Copied contents to your clipboard!